Freenome

Blood and fluid testing for cancer biomarkers, from early detection to residual disease monitoring.

Vetted listing

Testing

Consented intake · your records travel with you · nothing moves without your sign-off

Why Freenome exists

Freenome provides liquid biopsy testing that gathers and analyzes blood and other bodily fluids for biomarkers including DNA, RNA, and proteins. The testing spans early detection through minimum residual disease monitoring. For patients, it offers biomarker information that can guide treatment choices and track how the disease is progressing over time.

FDA approved · SimpleScreen CRC is approved by the FDA for colorectal cancer screeningCLIA certified clinical laboratoryFounded in 2014

Prefer the source? Freenome's own site has more.

Share your records

We'll pre-fill the intake from your records — no retyping.

Start sharing →

Check your coverage

See if your insurance covers this and estimate out-of-pocket cost.

Check coverage →

Coverage, insurance & cost

The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Freenome handles billing.

We don't have confirmed insurance details for Freenome yet. Start a coverage check with your plan, or contact the provider directly.

Ask about this service

Answers grounded in Freenome's details here. Educational only; your oncologist directs treatment.

Ask OpenCancer · answers grounded in this storefront

Who this is for

Cancer types served

colorectal

Also consider

Other providers in similar categories.

BostonGene

6 offerings

Gather distinctive biomarkers that can guide treatment and monitor disease progression

Foundation Medicine

6 offerings

FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.